抗凝血因子Ⅱ(F2)單克隆抗體
Anti-Coagulation Factor II (F2) Monoclonal Antibody
FII; TM; PT; Thrombin; Prothrombin; Pro-Thrombin; Activation peptide fragment 1; Activation peptide fragment 2
產品包裝(模擬)
產品包裝(模擬)
Human HepG2 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10μg/ml mouse Anti-human F2 Monoclonal Antibody (Catalog FAA820Hu02, red histogram) or Isotype control antibody (Catalog IS067-Mu01, green histogram), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
通過ISO 9001、ISO 13485質量體系認證
用法
Flow cytometry: 10μg/ml;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過一年。避免反復凍融。
贈品
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| NPA820Hu01 | 凝血因子Ⅱ(F2)天然蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA820Hu02 | 凝血因子Ⅱ(F2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA820Hu03 | 凝血因子Ⅱ(F2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA820Hu01 | 凝血因子Ⅱ(F2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA820Hu02 | 凝血因子Ⅱ(F2)多克隆抗體 | WB; IHC |
| PAA820Hu01 | 凝血因子Ⅱ(F2)多克隆抗體 | WB; IHC; ICC; IP. |
| MAA820Hu27 | 凝血因子Ⅱ(F2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA820Hu29 | 凝血因子Ⅱ(F2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA820Hu23 | 凝血因子Ⅱ(F2)單克隆抗體 | WB |
| MAA820Hu24 | 凝血因子Ⅱ(F2)單克隆抗體 | WB; ICC/IF |
| MAA820Hu25 | 凝血因子Ⅱ(F2)單克隆抗體 | WB |
| MAA820Hu22 | 凝血因子Ⅱ(F2)單克隆抗體 | WB; IHC |
| MAA820Hu21 | 凝血因子Ⅱ(F2)單克隆抗體 | WB |
| FAA820Hu02 | 抗凝血因子Ⅱ(F2)單克隆抗體 | FCM |
| FAA820Hu04 | 抗凝血因子Ⅱ(F2)單克隆抗體 | FCM |
| SEA820Hu | 凝血因子Ⅱ(F2)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| AEA820Hu | 抗凝血因子Ⅱ抗體(Anti-F2)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antibody Detection. |
| SCA820Hu | 凝血因子Ⅱ(F2)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA820Hu | 凝血因子Ⅱ(F2)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Blood Cells Mol Dis | Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients[Pubmed:35180460] |